Literature DB >> 25596666

HIF-α Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression.

Heng Chen1, Yunfeng Shen2, Fang Gong1, Yuanqiang Jiang2, Ri Zhang3.   

Abstract

We sought to determine the expression levels of hypoxia-inducible factor-1α (HIF-1α) in the bone marrow chronic myelogenous leukemia (CML) patients. We also tried to determine the roles HIF-1α in the proliferation of CML cells by small interfering RNA (siRNA) knockdown. Real-time PCR was performed to determine the expression levels of HIF-1α in the bone marrows of CML patients and healthy volunteers. HIF-1α knockdown by siRNA in K562 cells was confirmed by RT-PCR. Proliferation and colony formation of the treated cells were determined by CCK8 after HIF-1α knockdown. RT-PCR and western blotting were performed to detect mRNA and protein levels of p21 and p53 in K562 cells. HIF-1α mRNA expression in the bone marrow of CML patients was significantly higher than that in the control, which was statistically significant (P < 0.05). HIF-1α knockdown dramatically reduced the proliferation of K562 cells, which was also statistically significant (P < 0.05). HIF-1α knockdown markedly reduced the colony formation ability of K562 cells, which was also statistically significant (P < 0.05). The mRNA and protein expression of p21 were significantly reduced in K562 cell after HIF-1α knockdown with affecting the mRNA and protein levels of p53. HIF-α promotes chronic CML cell proliferation by up-regulating p21 expression.

Entities:  

Keywords:  Chronic myeloid leukemia; HIF-1α; p21; p53

Mesh:

Substances:

Year:  2015        PMID: 25596666     DOI: 10.1007/s12013-014-0434-2

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  10 in total

Review 1.  Integration of hypoxic HIF-α signaling in blood cancers.

Authors:  L Schito; S Rey; M Konopleva
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

2.  Altered intracellular signaling by imatinib increases the anti-cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells.

Authors:  Takuya Hirao; Masashi Yamaguchi; Megumi Kikuya; Hiroji Chibana; Kousei Ito; Shigeki Aoki
Journal:  Cancer Sci       Date:  2017-12-07       Impact factor: 6.716

3.  Global transcriptomic analysis suggests carbon dioxide as an environmental stressor in spaceflight: A systems biology GeneLab case study.

Authors:  Afshin Beheshti; Egle Cekanaviciute; David J Smith; Sylvain V Costes
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

Review 4.  Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Authors:  Yammy Yung; Emily Lee; Hiu-Tung Chu; Pui-Kwan Yip; Harinder Gill
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

Review 5.  Chronic myeloid leukemia stem cells: targeting therapeutic implications.

Authors:  Hanieh Mojtahedi; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Stem Cell Res Ther       Date:  2021-12-18       Impact factor: 6.832

6.  Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1α Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells.

Authors:  Yuexian Zhang; Heng Chen; Yunfeng Shen; Xin Zhou
Journal:  J Immunol Res       Date:  2022-04-28       Impact factor: 4.493

Review 7.  Hypoxic stress and hypoxia-inducible factors in leukemias.

Authors:  Daniela Magliulo; Rosa Bernardi
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

8.  Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.

Authors:  Ping Liu; Haijun Zhang; Xue Wu; Liting Guo; Fei Wang; Guohua Xia; Baoan Chen; HaiXiang Yin; Yonglu Wang; Xueming Li
Journal:  Onco Targets Ther       Date:  2016-08-12       Impact factor: 4.147

Review 9.  Hypoxia and Hypoxia-Inducible Factors in Leukemias.

Authors:  Margaux Deynoux; Nicola Sunter; Olivier Hérault; Frédéric Mazurier
Journal:  Front Oncol       Date:  2016-02-26       Impact factor: 6.244

10.  SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1α axis.

Authors:  Francesca Monteleone; Simona Taverna; Riccardo Alessandro; Simona Fontana
Journal:  J Exp Clin Cancer Res       Date:  2018-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.